Quest PharmaTech (TSXV:QPT) COGS-to-Revenue : 0.00 (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech COGS-to-Revenue?

Quest PharmaTech's Cost of Goods Sold for the three months ended in Oct. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Oct. 2023 was C$0.00 Mil.

Quest PharmaTech's COGS to Revenue for the three months ended in Oct. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Quest PharmaTech's Gross Margin % for the three months ended in Oct. 2023 was N/A%.

Quest PharmaTech COGS-to-Revenue Historical Data

The historical data trend for Quest PharmaTech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech COGS-to-Revenue Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

COGS-to-Revenue

Get a 7-Day Free Trial

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Quest PharmaTech COGS-to-Revenue Calculation

Quest PharmaTech's COGS to Revenue for the fiscal year that ended in Jan. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Quest PharmaTech's COGS to Revenue for the quarter that ended in Oct. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Quest PharmaTech (TSXV:QPT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Quest PharmaTech's Gross Margin % for the three months ended in Oct. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Quest PharmaTech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines